It has a 18.62 P/E ratio. It offers a range of products that are used in end-products, such as enterprise and data center networking, home connectivity, set-top boxes (STBs), broadband access, telecommunication equipment, smartphones, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays.
Weiss Multi-Strategy Advisers Llc increased Bristol Myers (BMY) stake by 29.84% reported in 2016Q4 SEC filing.
Microsoft Corporation most recently reported earnings per share (EPS) of $0.98 for the June 2017 versus $0.69 in the same quarter past year, representing 42% growth. The stock declined 0.22% or $0.14 reaching $62.7 on the news. The shares went up by 10.42% in value last month.
Bristol-Myers Squibb Company (BMY) has broken the weak rising the short-term trend up and an even stronger rising rate is indicated. It has underperformed by 39.89% the S&P500.
About 17,476 shares traded. It has outperformed by 47.30% the S&P500. The firm earned "Hold" rating on Tuesday, March 15 by Jefferies.
HD Supply Holdings Inc (HDS) formed double bottom with $32.21 target or 4.00% below today's $33.55 share price. InvenSense had 22 analyst reports since August 5, 2015 according to SRatingsIntel. Atlantic Securities downgraded Twitter Inc (NYSE:TWTR) on Friday, February 10 to "Underweight" rating. On Wednesday, April 26 the stock rating was initiated by Robert W. Baird with "Outperform". Also, the Hold rating count is 1, as of 07 Sep 2017.
In other news, Director Theodore R. Samuels II acquired 6,000 shares of the stock in a transaction on Wednesday, August 2nd.
Since the beginning of the calendar year, the stock is 12.24%. Stifel Nicolaus maintained the stock with "Hold" rating in Monday, January 30 report. Gradient Investments LLC lifted its stake in shares of Bristol-Myers Squibb by 9.1% in the 1st quarter. Moreover, Orbis Investment Management (U.S.) Llc has 8.05% invested in the company for 171,931 shares.
Before trading, trader, investor or shareholder must have an eye on stock's historical performance. The California-based Van Hulzen Asset Management Ltd Llc has invested 0.2% in Bristol-Myers Squibb Co (NYSE:BMY).
Bristol-Myers Squibb Company (NYSE:BMY) gained 4.96% in yesterday's trading session, going up from its prior closing price of $59.87 to $62.84, and has now recorded rally in 3 consecutive sessions. Therefore 44% are positive. Bristol-Myers Squibb has a 52 week low of $46.01 and a 52 week high of $63.47. The firm earned "Hold" rating on Thursday, July 14 by Jefferies. The firm has "Hold" rating by Topeka Capital Markets given on Friday, July 24. Citigroup maintained Bristol-Myers Squibb Co (NYSE:BMY) rating on Tuesday, September 20. BMO Capital Markets has "Sell" rating and $49.0 target. Northland Capital maintained InvenSense Inc (NYSE:INVN) rating on Thursday, October 29.
The analysts offering 12 month price targets for Bristol-Myers Squibb Company have a median target of $60, with a high estimate of $68 and a low estimate of $49. (NASDAQ:QCOM) on Wednesday, December 21 with "Neutral" rating. The firm has "Market Perform" rating given on Monday, January 25 by BMO Capital Markets. Its down 0.03, from 0.98 in 2016Q3. 111 funds opened positions while 527 raised stakes. On average, analysts forecast that Bristol-Myers Squibb Company will post $2.98 EPS for the current year. 15,148 are held by Palisade Mngmt Lc Nj.
Investors sentiment decreased to 0.95 in 2016 Q4. The stock increased 0.79% or $0.16 on September 7, reaching $20.46. Gradient Investments LLC now owns 2,401 shares of the biopharmaceutical company's stock valued at $131,000 after purchasing an additional 200 shares during the period. The stock has "Equal Weight" rating by Barclays Capital on Tuesday, December 1. Bristol-Myers Squibb Company had a return on equity of 31.39% and a net margin of 22.94%. Finally, First PREMIER Bank lifted its stake in shares of Bristol-Myers Squibb by 14.3% in the 1st quarter. Daiwa Sb Ltd invested in 2.32% or 151,050 shares. Tirschwell And Loewy holds 0.1% or 9,900 shares. Finally, Blue Chip Partners Inc. grew its stake in Bristol-Myers Squibb by 0.8% during the 1st quarter. (NASDAQ:AMGN). Gradient Investments Limited Liability Company holds 0.49% or 38,547 shares. Swiss National Bank boosted its holdings in stocks of Bristol-Myers Squibb by 27.2% during the Q1.